הלוואות ואשראי לטווח ארוך של החברה Catheter Precision Corporation (VTAK)

Serving as the primary valuation tool, this Catheter Precision (VTAK) price chart demonstrates the dynamics of a company creating a high-tech environment for cardiac mapping, where V-Centric systems establish significant barriers for clinics switching to alternative software. VektorPlus intelligent algorithms independently identify arrhythmia zones, achieving a peak in automation. The current metric stands at 0.03, while the reliability of consumable supplies is guaranteed via direct air freight to operating rooms.

This indicator captures the total volume of liabilities with a maturity exceeding one year, reflecting the asset financing strategy. By analyzing the firm's long-term debt capital, an investor assesses the credit load and financial stability. The metric is sensitive to changes in interest rates and the cost of debt service. Stability in this figure indicates a balance between risk and expansion, which is critical for Catheter Precision (VTAK) when investing in high-precision arrhythmia treatment systems.